Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
MedChat
AddedFeb 16, 2024
UpdatedJun 18, 2026
MedChat

MedChat

Seed

MedChat: A secure healthcare communication platform automating patient interactions with robust data encryption.

HQ
Charlotte, NC, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

MedChat was founded with the core mission of revolutionizing healthcare communication by automating patient interactions while ensuring data security. The platform offers a suite of services including live chat, texting, email, and voice communication, all integrated into a single, secure system. MedChat focuses on providing healthcare companies with tools to automate workflows and enhance productivity using AI agents. The platform is built with robust encryption protocols to protect personal health information, catering primarily to innovative healthcare providers.

Notable affiliations include partnerships with leading healthcare companies that are at the forefront of transformative care. MedChat has achieved significant milestones, such as a 22% decrease in call volume and a 59% increase in new patients for its users. Its impact on the healthcare industry is marked by improved efficiency and enhanced patient engagement, making it a valuable asset for modern healthcare communication needs.

MedChat - Similar Companies

medEchat logo

medEchat

medechat.com

Medici logo

Medici

MedRespond logo

MedRespond

medrespond.com

DocTalk logo

DocTalk

getdoctalk.com

MDconnectME logo

MDconnectME

Vital Interaction logo

Vital Interaction

Mediprocity logo

Mediprocity

mediprocity.com

HealthTalk A.I. logo

HealthTalk A.I.

healthtalkai.com

MicroMed logo

MicroMed

Lifelink Systems logo

Lifelink Systems

CipherHealth logo

CipherHealth

cipherhealth.com

Doctible logo

Doctible

doctible.com

Conex Med/Pro Systems logo

Conex Med/Pro Systems

Bot MD logo

Bot MD

botmd.io

Medigram logo

Medigram

medigram.com

MedChat - Quick Facts

Who are MedChat's competitors?

Companies similar to MedChat include medEchat, Medici, MedRespond and DocTalk.

When was MedChat founded?

MedChat was founded in 2015.

Where is MedChat's headquarters located?

MedChat's headquarters is located in Charlotte, NC, US.

When was MedChat's last funding round?

MedChat's most recent funding round was for $2.3M (USD) in July 2021.

How much has MedChat raised to-date?

As of Jul 21, 2021, MedChat has raised a total of $2.3M (USD).

How many employees does MedChat have?

MedChat has 17 employees as of Feb 4, 2024.

MedChat - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Automation
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
  • Usage-based
Customer
  • Enterprise
Main Product
  • Healthcare Communication
Tags
  • Healthtech
  • SaaS
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software